linsidomine has been researched along with Cancer of Prostate in 2 studies
linsidomine: RN given refers to parent cpd; structure
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Patra, N | 1 |
| De, U | 1 |
| Kang, JA | 1 |
| Kim, JM | 1 |
| Ahn, MY | 1 |
| Lee, J | 1 |
| Jung, JH | 1 |
| Chung, HY | 1 |
| Moon, HR | 1 |
| Kim, HS | 1 |
| Juang, HH | 1 |
2 other studies available for linsidomine and Cancer of Prostate
| Article | Year |
|---|---|
A novel epoxypropoxy flavonoid derivative and topoisomerase II inhibitor, MHY336, induces apoptosis in prostate cancer cells.
Topics: Antineoplastic Agents; Apoptosis; Biocatalysis; Cell Cycle; Cell Line, Tumor; Cell Proliferation; DN | 2011 |
Nitroprusside stimulates mitochondrial aconitase gene expression through the cyclic adenosine 3',5'-monosphosphate signal transduction pathway in human prostate carcinoma cells.
Topics: Aconitate Hydratase; Ascorbic Acid; Blotting, Western; Cell Line, Tumor; Cyclic AMP; Free Radical Sc | 2004 |